HMOX1 and cystic fibrosis: Importantly, modulation of this pathway via overexpression of HO-1 or treatment with CO-releasing molecules (discussed in the next section) was sufficient to improve the signaling cascade, thus reducing hyper-inflammation in CF MΦs (Zhang et al., 2013).